Rankings
▼
Calendar
TKNO Q2 2020 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$135M
Q2 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$6M
Gross Profit
$3M
57.4% margin
Operating Income
$704,000
11.6% margin
Net Income
$512,000
8.5% margin
EPS (Diluted)
$0.00
QoQ Revenue Growth
-1.1%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$1M
Stock-Based Comp.
$0
← FY 2020
All Quarters
Q3 2020 →